助手标题
全文文献 工具书 数字 学术定义 翻译助手 学术趋势 更多
查询帮助
意见反馈
共[4]页 共[68]条 当前为第1条到20条
 

相关语句
transdermal fentanyl
Usefulness of transdermal fentanyl in the management of nonmalignant chronic pain: A prospective, observational, multicenter stu
      
A total of 236 patients with chronic non-cancer pain suitable to be treated with transdermal fentanyl participated in a prospective, observational, noncomparative, open-label multicenter study.
      
Transdermal fentanyl is a safe and effective method of managing chronic nonmalignant pain.
      
Transdermal fentanyl for the treatment of pain after major urological operations
      
Transdermal fentanyl 75 μg/h (Fentanyl-TTS) was compared with placebo in a randomized double-blind study in the early postoperative period, using 50 patients recovering from major urological operations.
      
Transdermal fentanyl may be useful but has not been studied systematically.
      
Patients with at least one osteoporotic vertebral fracture requiring strong opioids were enrolled and received transdermal fentanyl.
      
Transdermal fentanyl is useful for the treatment of severe back pain caused by osteoporosis.
      
Transdermal fentanyl for the treatment of pain caused by rheumatoid arthritis
      
This study evaluated transdermal fentanyl (TDF) for the treatment of pain from rheumatoid arthritis (RA) which was not adequately controlled by nonopioid analgesics and/or weak opioids.
      
Transdermal fentanyl should be considered in treatment programs for patients with RA.
      
Fatal outcome in a child after ingestion of a transdermal fentanyl patch
      
The autopsy revealed a 25-μg/h (4.2?mg) transdermal fentanyl patch in the stomach.
      
Transdermal fentanyl in uncontrolled cancer pain: titration on a day-to-day basis as a procedure for safe and effective dose fin
      
Day-to-day titration of transdermal fentanyl is unwise
      
Is the use of transdermal fentanyl inappropriate according to the WHO guidelines and the EAPC recommendations A study of cancer
      
We carried out a cost-effectiveness evaluation of transdermal fentanyl compared to three other widely used opioids: transdermal buprenorphine, sustained-release morphine, and controlled-release oxycodone from a third-party-payers perspective.
      
Transdermal fentanyl patients gain more quality adjusted life-days or quality-adjusted life-years per euro.
      
The incremental cost per quality-adjusted life-year is €1,625.65 for transdermal fentanyl compared to sustained-release morphine and €1,003.03 compared to CO, and it is cost-saving compared to transdermal buprenorphine (-€203.38 per patient).
      
Transdermal fentanyl is thus cost-effective compared to both sustained-release morphine and CO and dominant compared to transdermal buprenorphine in the treatment of adults with nonmalignant moderate to severe chronic pain.
      
 

首页上一页1234下一页尾页 

 
CNKI主页设CNKI翻译助手为主页 | 收藏CNKI翻译助手 | 广告服务 | 英文学术搜索
版权图标  2008 CNKI-中国知网
京ICP证040431号 互联网出版许可证 新出网证(京)字008号
北京市公安局海淀分局 备案号:110 1081725
版权图标 2008中国知网(cnki) 中国学术期刊(光盘版)电子杂志社